Press Release VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets 9 hours ago
Press Release Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis 10 hours ago